J. Eymard

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

F. Bertucci, F. André, J. Lemonnier, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort

M. Mouret-Reynier, O. Rigal, M. Chevrot, 2021, Breast Cancer Research and Treatment.

Adjuvant radiation therapy for malignant Abrikossoff’s tumor: a case report about a femoral triangle localisation

F. Guillemin, C. Garbar, S. Servagi Vernat, 2018, Radiation Oncology.

De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.

V. Diéras, F. Dalenc, M. Chevrot, 2021, European journal of cancer.

CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database

M. Campone, T. Petit, F. Dalenc, 2019, Breast.

Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer.

D. Spaeth, I. Treilleux, T. Bachelot, 2015 .

Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer.

D. Spaeth, I. Treilleux, T. Bachelot, 2015, Annals of Oncology.

Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation

S. Delaloge, T. Bachelot, M. Chevrot, 2023, British Journal of Cancer.

UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.

J. Lemonnier, J. Pierga, P. Viens, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.